Announcement on Implementation Results of Share Repurchase and Share Changes
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Implementation Results of Share Repurchase and Share Changes
Filed with SSE ·
On 6ix: 6ix.com/news/announcement-on-implementation-results-of-share-repurchase-and-share-changes-44
6ix hasn’t read this filing yet.
Shanghai Shen Lian Biomedical Corporation on 6ix
Earlier from Shanghai Shen Lian Biomedical
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Attending the Collective Annual Report Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2025 and Convening the Q1 2025 Report Performance Briefing
- Announcement on Progress in Repurchasing Shares through Call Auction
- 2024 Annual Report
- Announcement on Voluntary Disclosure of Passing GCP Supervision and Inspection for Veterinary Drugs by Ministry of Agriculture and Rural Affairs (MOA)
Later from Shanghai Shen Lian Biomedical
- Announcement on Voluntary Disclosure of Approval Numbers for Approved Veterinary Drug Products
- Announcement on Voluntary Disclosure of Registration Approval for New Veterinary Drug Products
- Announcement on the Signing of a Cooperative Development Agreement for Multivalent Vaccine Projects with Lanzhou Veterinary Research Institute of the Chinese Academy of Agricultural Sciences
- Announcement on Abnormal Fluctuations in Stock Trading
- Special Report on Deposit and Use of Raised Funds in January-June 2025
Follow Shanghai Shen Lian Biomedical into a list and get an email when it puts out news.
Follow Shanghai Shen Lian Biomedical